imiquimod has been researched along with nigericin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, D; Chen, G; Lin, J; Lin, Y; Liu, A; Luo, T; Ouyang, D; Pan, H; Qin, M; Zhou, X | 1 |
Cang, J; Chen, G; He, Q; Wang, C; Wang, Y; Yu, J; Zhong, M | 1 |
2 other study(ies) available for imiquimod and nigericin
Article | Year |
---|---|
Corilagin Restrains NLRP3 Inflammasome Activation and Pyroptosis through the ROS/TXNIP/NLRP3 Pathway to Prevent Inflammation.
Topics: Adenine; Adenosine Triphosphate; Anti-Inflammatory Agents; Antioxidants; Arthritis, Gouty; Caspase 1; Humans; Hydrolyzable Tannins; Imiquimod; Inflammasomes; Inflammation; Interleukin-1beta; Lactate Dehydrogenases; Lipopolysaccharides; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Nucleosides; Propidium; Pyroptosis; Reactive Oxygen Species; Uric Acid | 2022 |
Inhibition of sphingosine-1-phosphate receptor 3 suppresses ATP-induced NLRP3 inflammasome activation in macrophages
Topics: Adenosine Triphosphate; Animals; Imiquimod; Inflammasomes; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred C57BL; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Potassium; RNA, Messenger; Sphingosine-1-Phosphate Receptors | 2023 |